
|Videos|January 31, 2019
Advances in Molecular Subtyping of Colon Cancer
Author(s)Scott Kopetz, MD, PhD
Cancer Network spoke with Dr. Scott Kopetz about RNA-based subtyping and the challenge of spreading the word of the importance of biomarker testing in colorectal cancer.
Advertisement
Cancer Network spoke with Dr. Scott Kopetz about RNA-based subtyping and the challenge of spreading the word of the importance of biomarker testing in colorectal cancer.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care
2
FDA Approves Niraparib Regimen in BRCA2+ Metastatic CSPC
3
How Should a Patient With Multiple Myeloma Manage Talquetamab’s Toxicity?
4
EMD Associated With Poorer Outcomes in Previously Treated R/R Multiple Myeloma
5

















































































